Medicine Man Technologies, Inc. Quarterly Cost of Revenue in USD from Q2 2016 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Medicine Man Technologies, Inc. quarterly/annual Cost of Revenue history and growth rate from Q2 2016 to Q3 2023.
  • Medicine Man Technologies, Inc. Cost of Revenue for the quarter ending September 30, 2023 was $25.3M, a 22.2% increase year-over-year.
  • Medicine Man Technologies, Inc. Cost of Revenue for the twelve months ending September 30, 2023 was $73.8M, a 1.62% decline year-over-year.
  • Medicine Man Technologies, Inc. annual Cost of Revenue for 2022 was $74.3M, a 25.9% increase from 2021.
  • Medicine Man Technologies, Inc. annual Cost of Revenue for 2021 was $59.1M, a 243% increase from 2020.
  • Medicine Man Technologies, Inc. annual Cost of Revenue for 2020 was $17.2M, a 126% increase from 2019.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $73.8M $25.3M +$4.59M +22.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $69.2M $17.9M -$1.25M -6.55% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $70.5M $17M -$3.87M -18.6% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $74.3M $13.7M -$687K -4.78% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-29
Q3 2022 $75M $20.7M +$3.94M +23.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $71.1M $19.1M +$3.28M +20.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $67.8M $20.8M +$8.75M +72.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $59.1M $14.4M +$7.05M +96.3% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-29
Q3 2021 $52M $16.8M +$12.1M +261% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $39.9M $15.8M +$12.7M +409% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $27.2M $12.1M +$9.94M +463% Jan 1, 2021 Mar 31, 2021 10-Q/A 2022-05-27
Q4 2020 $17.2M $7.32M +$5.18M +241% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 $12M $4.65M +$1.86M +66.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $10.2M $3.11M +$2.02M +186% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $8.17M $2.15M +$550K +34.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $7.62M $2.14M +$781K +57.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 $6.84M $2.79M +$2.33M +507% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 $4.51M $1.09M +$706K +186% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 $3.8M $1.6M +$1.23M +328% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 $2.58M $1.36M +$796K +140% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 $1.78M $459K +$162K +54.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $1.62M $380K +$108K +39.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $1.51M $374K +$208K +126% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-20
Q4 2017 $1.3M $568K Oct 1, 2017 Dec 31, 2017 10-K 2019-04-16
Q3 2017 $297K +$214K +257% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $272K +$228K +516% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $165K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-03
Q3 2016 $83.2K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $44.2K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.